Perspective Therapeutics (CATX) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Perspective Therapeutics (CATX) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 66.99% |
| 10 | Perspective Therapeutics | 308.74 Mn | 308.74 Mn | - | -57.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.91% |
| Dec 31, 2025 | -201.00% |
| Sep 30, 2025 | -58.72% |
| Jun 30, 2025 | 67.42% |
| Mar 31, 2025 | 61.97% |
| Dec 31, 2024 | 226.66% |
| Sep 30, 2024 | 61.22% |
| Jun 30, 2024 | -65.30% |
| Mar 31, 2024 | 17.30% |
| Jun 30, 2016 | -3,621.66% |
| Sep 30, 2015 | -241.33% |
| Jun 30, 2015 | 103.02% |
| Sep 30, 2014 | 79.80% |
| Jun 30, 2014 | 97.69% |
| Sep 30, 2013 | 99.11% |
| Jun 30, 2013 | -6,007,902.21% |
| Sep 30, 2012 | -1,495.79% |
| Jun 30, 2012 | 48.77% |
| Mar 31, 2012 | -5,783.71% |
| Dec 31, 2011 | -507.25% |